Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Oropharyngeal & Esophageal Candidiasis |
Dose: Buccal tablet – 1 tablet Frequency: once daily Duration: 7-14 days Note: apply in the morning |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: less than 16 years |
Dose: Buccal tablet – dose not established Note: Safety and efficacy not established |
|
Age: 16 years or older |
Dose: Buccal tablet – 1 tablet Frequency: once daily Duration: 7-14 days Note: apply in the morning |
Administration
- Place tablet against the upper gum
- Do not crush, chew, or swallow
Side Effect
- Diarrhea (6%)
- Nausea (4.6%)
- Headache (5%)
- Dysgeusia (2.9%)
- Upper abdominal pain (2.5%)
- Vomiting (2.5%)
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Warfarin
|
May increase anticoagulant effect
|
|
Oral hypoglycaemics, Phenytoin, HIV Protease Inhibitors (Ritonavir, Atazanavir, Lopinavir, Nelfinavir, Saquinavir, Indinavir), Antineoplastic agents, Ca channel blockers, Immunosuppressive agents, Carbamazepine, Cilostazol, Buspirone, Disopyramide, Alfentanil, Sildenafil, Alprazolam, Brotizolam, Midazolam IV, Rifabutin, Methylprednisolone, Trimetrexate, Ebastine, Reboxetine
|
May increase or prolong the effect
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Hepatic Impairment
|
Can affect drug metabolism
|
|
Porphyria
|
Risk of acute attacks
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Details coming soon
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.